ES2164147T3 - Nuevas formas cristalinas de la 2-(5-metanosulfonamido-indolil-2-carbonil)-4-(3-(1-metiletilamino)-2-piperidinil)piperazina. - Google Patents

Nuevas formas cristalinas de la 2-(5-metanosulfonamido-indolil-2-carbonil)-4-(3-(1-metiletilamino)-2-piperidinil)piperazina.

Info

Publication number
ES2164147T3
ES2164147T3 ES95911842T ES95911842T ES2164147T3 ES 2164147 T3 ES2164147 T3 ES 2164147T3 ES 95911842 T ES95911842 T ES 95911842T ES 95911842 T ES95911842 T ES 95911842T ES 2164147 T3 ES2164147 T3 ES 2164147T3
Authority
ES
Spain
Prior art keywords
carbonil
methylethylamine
piperazine
crystalline forms
methanosulphonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95911842T
Other languages
English (en)
Inventor
Jeffrey L Havens
Donald P Smith
Michael S Bergren
Mark A Lyster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2164147T3 publication Critical patent/ES2164147T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DOS NUEVAS FORMAS CRISTALINAS DE UN COMPUESTO CONOCIDO, LA SAL MONOMETANOSULFONADA DE 1-[5-METANOSULFONAMIDOINDOLIL-2-CARBONIL]-4-[3-(1-METILETILAMINO)-2-PIRIDINIL]PIPERAZINA, QUE SON IDENTIFICADAS POR UN ESPECTRO DE DIFRACCION DE POLVO DE RAYOS-X CONOCIDAS COMUNMENTE COMO LAS FORMAS "S" Y "T"
ES95911842T 1994-04-15 1995-03-01 Nuevas formas cristalinas de la 2-(5-metanosulfonamido-indolil-2-carbonil)-4-(3-(1-metiletilamino)-2-piperidinil)piperazina. Expired - Lifetime ES2164147T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22786094A 1994-04-15 1994-04-15
US31178094A 1994-09-23 1994-09-23

Publications (1)

Publication Number Publication Date
ES2164147T3 true ES2164147T3 (es) 2002-02-16

Family

ID=26921831

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95911842T Expired - Lifetime ES2164147T3 (es) 1994-04-15 1995-03-01 Nuevas formas cristalinas de la 2-(5-metanosulfonamido-indolil-2-carbonil)-4-(3-(1-metiletilamino)-2-piperidinil)piperazina.

Country Status (26)

Country Link
US (1) US6452007B1 (es)
EP (1) EP0755393B1 (es)
JP (1) JP3817261B2 (es)
KR (1) KR100364941B1 (es)
CN (1) CN1147253A (es)
AT (1) ATE207481T1 (es)
AU (1) AU693939B2 (es)
CA (1) CA2184598C (es)
CZ (1) CZ287164B6 (es)
DE (1) DE69523447T2 (es)
DK (1) DK0755393T3 (es)
ES (1) ES2164147T3 (es)
FI (1) FI111364B (es)
HU (1) HU226827B1 (es)
IL (1) IL113162A (es)
LV (1) LV12957B (es)
MX (1) MX9604831A (es)
MY (1) MY116830A (es)
NO (1) NO310024B1 (es)
NZ (1) NZ282211A (es)
PL (1) PL180776B1 (es)
PT (1) PT755393E (es)
RU (1) RU2136677C1 (es)
SK (1) SK282424B6 (es)
TW (1) TW393478B (es)
WO (1) WO1995028398A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9910481A (pt) 1998-06-11 2001-01-09 Upjohn Co Composição farmacêutica para comprimido de liberação não-contìnua
US6872811B1 (en) 1998-09-30 2005-03-29 Millennium Pharmaceuticals, Inc. HRPCa9 and HRPCa10 nucleic acids and polypeptides
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565924A (en) 1968-07-01 1971-02-23 Wisconsin Alumni Res Found 25-hydroxycholfcalciferol
US3833622A (en) 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
GB1532682A (en) 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
ES2093090T3 (es) * 1989-12-28 1996-12-16 Upjohn Co Compuestos sustituidos diaromaticos anti-sida.
US5599930A (en) * 1991-07-03 1997-02-04 The Upjohn Company Substituted indoles as anti-AIDS pharmaceuticals

Also Published As

Publication number Publication date
CN1147253A (zh) 1997-04-09
HU9602857D0 (en) 1996-12-30
ATE207481T1 (de) 2001-11-15
FI111364B (fi) 2003-07-15
SK122996A3 (en) 1997-05-07
AU3513695A (en) 1995-11-10
JP3817261B2 (ja) 2006-09-06
NO964386D0 (no) 1996-10-15
HU226827B1 (en) 2009-11-30
PL316688A1 (en) 1997-02-03
IL113162A (en) 1999-04-11
FI964114A (fi) 1996-10-14
JPH09512007A (ja) 1997-12-02
EP0755393B1 (en) 2001-10-24
LV12957B (en) 2003-04-20
NO964386L (no) 1996-10-15
KR100364941B1 (ko) 2003-02-19
CA2184598A1 (en) 1995-10-26
DE69523447T2 (de) 2002-05-16
PT755393E (pt) 2002-04-29
KR970702275A (ko) 1997-05-13
SK282424B6 (sk) 2002-01-07
EP0755393A1 (en) 1997-01-29
AU693939B2 (en) 1998-07-09
HUT76467A (en) 1997-09-29
RU2136677C1 (ru) 1999-09-10
WO1995028398A1 (en) 1995-10-26
NO310024B1 (no) 2001-05-07
MX9604831A (es) 1998-05-31
US6452007B1 (en) 2002-09-17
PL180776B1 (pl) 2001-04-30
MY116830A (en) 2004-04-30
DE69523447D1 (de) 2001-11-29
IL113162A0 (en) 1995-06-29
CZ294296A3 (en) 1997-01-15
TW393478B (en) 2000-06-11
CA2184598C (en) 2005-05-03
DK0755393T3 (da) 2001-12-17
NZ282211A (en) 1997-10-24
FI964114A0 (fi) 1996-10-14
CZ287164B6 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
DK1244435T3 (da) Polyhydroxylerede, aromatiske forbindelser til behandling af amyloidose og alpha-synuclein fibril sygdomme
NO992770L (no) Nye heterocyklisk substituerte benzamider og deres anvendelse ved bekjempelse av sykdommer
ATE227277T1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
BR9812837A (pt) Processo para fazer um composto, e, composto
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
PA8486701A1 (es) Antagonistas de 5ht1 para terapia antidepresiva
ES2164147T3 (es) Nuevas formas cristalinas de la 2-(5-metanosulfonamido-indolil-2-carbonil)-4-(3-(1-metiletilamino)-2-piperidinil)piperazina.
BR0209430A (pt) Compostos heterocìclicos
BR9808923A (pt) Composto, e, processo para fazer o mesmo
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
FI852423L (fi) 1-(bis-(4-fluorofenyl)-metyl)- 4-(3-fenyl-2-propenyl)-hexahydro-1h-1,4-diazepin med kalciumantagonistverkan, dess framstaellning och kompositioner innehaollande densamma.
ES2114115T3 (es) Procedimiento y nuevos productos intermedios para la obtencion de triazolinonas.
ES2154692T3 (es) Dihidrofarnesal.
NO20000423L (no) Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene
DE60133914D1 (de) Substituierte 4,5-dihydro-1,2,4-triazin-3-one, 1,2,4-triazin-3-one sowie deren verwendung als fungizide und insektizide
DE69316623T2 (de) Synergistische antimikrobielle zusammensetzung, die 2-(2-brom-2-nitroethenyl) furan enthält
ATE122674T1 (de) Ethanoladdukte von 6-sulfonylsubstituierten 3- hydroxychromanen und ihre verwendung als inhalationsmittel bei krankheiten.
MX9704835A (es) N-acetonilbenzamidas heterociclicas.
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
BR9910979A (pt) Aplicação de 2,4-diamino-1,3,5-triazinas substituìdas para combater pragas animais
ATE194004T1 (de) Polymorphe a und b des 1-(piphenylmethyl)-4-(3-(2-phenyl-dioxolan-2-yl propyl)piperazins
RO83455A (ro) Procedeu pentru prepararea formei cristaline lafa a clorhidratului de1-(4-amino-6,7-dimetoxi-2-chinazolinil)-4-(2-furoil)-piperazina
PT1105388E (pt) Derivados de azabiciclo-heptano n-substituidos o seu fabrico e a sua utilizacao

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 755393

Country of ref document: ES